News | June 02, 2008

Results from RF Ablation Catheters Study Promising

June 3, 2008 - Two patients with permanent atrial fibrillation and three with paroxysmal atrial fibrillation underwent successful pulmonary vein isolation without any reported complications, according to Stefania Riva, M.D., who presented preliminary results of a study on new RF ablation catheters at the 7th Annual Session of the Italian Association of Arrhythmology and Cardiac Pacing on April 3, 2008 in Milan, Italy.

The procedures were conducted using the PVAC Pulmonary Vein Ablation Catheter and multi-channel GENius Generator for Ablation Catheters supplied by Ablation Frontiers. The PVAC was used for both mapping and ablating during the procedures.

The procedure times averaged 32 minutes and after three months median follow-up (range: one to five months), four of five patients were in sinus rhythm.

"The use of a single mapping and ablation catheter has streamlined and simplified the procedure," stated Dr. Riva. "The lack of perioperative and postoperative complications is of key importance. As of this date, one patient in our study with paroxysmal AF has stopped taking all anti-arrhythmic medications. While our study is still underway, I find these interim results quite encouraging."

"We are very much encouraged by these interim results and sincerely thank Paolo Della Bella, M.D., chief of the Arrhythmology Department at the University of Milan's Institute of Cardiology. stated Keegan Harper, Chief Executive Officer of Ablation Frontiers.

For more information: www.ablationfrontiers.com


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now